---
pmid: '36096339'
title: Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.
authors:
- Cogo S
- Tomkins JE
- Vavouraki N
- Giusti V
- Forcellato F
- Franchin C
- Tessari I
- Arrigoni G
- Cendron L
- Manzoni C
- Civiero L
- Lewis PA
- Greggio E
journal: Neurobiol Dis
year: '2022'
full_text_available: false
doi: 10.1016/j.nbd.2022.105858
---

# Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.
**Authors:** Cogo S, Tomkins JE, Vavouraki N, Giusti V, Forcellato F, Franchin C, Tessari I, Arrigoni G, Cendron L, Manzoni C, Civiero L, Lewis PA, Greggio E
**Journal:** Neurobiol Dis (2022)
**DOI:** [10.1016/j.nbd.2022.105858](https://doi.org/10.1016/j.nbd.2022.105858)

## Abstract

1. Neurobiol Dis. 2022 Nov;174:105858. doi: 10.1016/j.nbd.2022.105858. Epub 2022 
Sep 9.

Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.

Cogo S(1), Tomkins JE(2), Vavouraki N(3), Giusti V(4), Forcellato F(4), Franchin 
C(5), Tessari I(4), Arrigoni G(5), Cendron L(4), Manzoni C(6), Civiero L(7), 
Lewis PA(8), Greggio E(9).

Author information:
(1)Department of Biology, University of Padova, Padova, Italy; School of 
Biological Sciences, University of Reading, United Kingdom. Electronic address: 
s.cogo@reading.ac.uk.
(2)School of Pharmacy, University of Reading, Reading, United Kingdom; Centre 
for Misfolding Diseases, Department of Chemistry, University of Cambridge, 
United Kingdom.
(3)School of Pharmacy, University of Reading, Reading, United Kingdom; 
Department of Mathematics and Statistics, University of Reading, Reading, United 
Kingdom.
(4)Department of Biology, University of Padova, Padova, Italy.
(5)Department of Biomedical Sciences, University of Padova, Padova, Italy.
(6)School of Pharmacy, University College London, London, United Kingdom.
(7)Department of Biology, University of Padova, Padova, Italy; IRCCS San Camillo 
Hospital, Venice, Italy; Centro Studi per la Neurodegenerazione (CESNE), 
University of Padova, Italy.
(8)School of Pharmacy, University of Reading, Reading, United Kingdom; 
Department of Comparative Biomedical Sciences, Royal Veterinary College, London, 
United Kingdom; Department of Neurodegenerative Disease, UCL Queen Square 
Institute of Neurology, United Kingdom.
(9)Department of Biology, University of Padova, Padova, Italy; Centro Studi per 
la Neurodegenerazione (CESNE), University of Padova, Italy. Electronic address: 
elisa.greggio@unipd.it.

Mutations in SPG11, encoding spatacsin, constitute the major cause of autosomal 
recessive Hereditary Spastic Paraplegia (HSP) with thinning of the corpus 
callosum. Previous studies showed that spatacsin orchestrates cellular traffic 
events through the formation of a coat-like complex and its loss of function 
results in lysosomal and axonal transport impairments. However, the upstream 
mechanisms that regulate spatacsin trafficking are unknown. Here, using 
proteomics and CRISPR/Cas9-mediated tagging of endogenous spatacsin, we 
identified a subset of 14-3-3 proteins as physiological interactors of 
spatacsin. The interaction is modulated by Protein Kinase A (PKA)-dependent 
phosphorylation of spatacsin at Ser1955, which initiates spatacsin trafficking 
from the plasma membrane to the intracellular space. Our study provides novel 
insight in understanding spatacsin physio-pathological roles with mechanistic 
dissection of its associated pathways.

Copyright Â© 2022 The Authors. Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.nbd.2022.105858
PMID: 36096339 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of Competing Interest The authors 
declare that they have no conflict of interest.
